Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Yinyin Yuan Image

      Yinyin Yuan

      Department of Translational Molecular Pathology, Division of Pathology-Lab Medicine Div

      About Yinyin Yuan

      Dr. Yinyin Yuan is a professor and the Director of Computational Pathology Research Program at the Department of Translational Molecular Pathology. The mission of the Yuan lab is to design impact-driven strategies and artificial intelligence (AI) engines to accelerate the applications of AI and data science to pathology. The scientific focus is to decipher how the tumor microenvironment shapes the evolution of immune escape and drug resistance. Her team is developing cutting-edge technologies to study the spatial heterogeneity of the tumor microenvironment and how it shapes cancer genetic heterogeneity and clinical outcome.  

      As a Co-Lead of Focus Area One - Quantitative analysis and insight extraction from imaging and pathology data - in the Institute for Data Science in Oncology, Dr. Yuan is committed to building the computational infrastructure and data science capacity for pathology. This will enable accelerated, rigorous, and actionable approaches for building data science capacity with translational impacts in pathology. The vision is to create a new paradigm of technological advances and multidisciplinary convergences that will lead the way to novel digital biomarkers and ultimately to the new frontier of integrated diagnostics. 

      Dr. Yuan obtained degrees in computer science from the University of Science and Technology of China (USTC, BSc) and University of Warwick (MSc and PhD), and has won prestigious awards and fellowships including a Junior Research Fellowship from Wolfson College, University of Cambridge and Cancer Research UK Career Establishment Fellowship. From 2012 to 2022, she led the Computational Pathology and Integrative Genomics team at the institute of Cancer Research, London. There she built a pioneering interface between digital pathology, machine learning, and cancer biology with strong clinical applications, and was awarded the title of Professor of Computational Pathology in 2021. Her team currently leads artificial intelligence developments in computational pathology in several international scientific programs and consortiums include the Cancer Research UK-funded TRACERx Lung, Sarcoma Network Accelerator, Early detection for myeloma, Brain Tumour Award Target-GBM, and the NIH-funded Arizona Cancer Evolution Center and Breast Pre-Cancer Atlas.  

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Professor, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests

      Dr. Yinyin Yuan is a professor and Director of the Computational Pathology Research Program in the Department of Translational Molecular Pathology. Her research focuses on computational and artificial intelligence (AI) development for digital pathology images and data-driven discovery in cancer biology. Her work introduced spatial and ecology-inspired analysis of the tumor microenvironment using digital pathology, contributing to a shift in the field from density-based analysis toward spatial biology. By grounding AI development in cancer biology, her research provides analytical frameworks to understand how interactions between genetically diverse cancer cells and their microenvironment drive tumor evolution and the emergence of drug resistance.


      She co-leads Focus Area One – Quantitative Pathology and Medical Imaging within the Institute for Data Science in Oncology (IDSO), which integrates meaningful data extraction with MD Anderson’s unparalleled clinical expertise to transform the future of cancer. The focus area fosters collaborations to harness large-scale data from digital pathology and radiological imaging to provide accelerated, rigorous and actionable insight for patients.


      Dr. Yuan founded and co-directs the SEQUOIA program (Spatial Ecology & Quantitative pathOlogy Image Analytical Platform), an institutional initiative dedicated to building AI and data science capacity for pathology. SEQUOIA integrates data science and clinical pathology expertise, data and computational resources, and research programs across the IDSO, The Strategic Research Initiative Development (STRIDE), and The Pathology and Laboratory Medicine division, to create a collaborative ecosystem in digital pathology. The program aims to advance technological innovation and multidisciplinary collaboration toward digital biomarker discovery, enabling a new frontier in integrated diagnostics.


      Dr. Yuan received her BSc in Computer Science from the University of Science and Technology of China and her MSc and PhD in Computer Science from the University of Warwick. She has won prestigious awards and fellowships, including a Junior Research Fellowship from Wolfson College, University of Cambridge, UK. Prior to joining MD Anderson, she led the Computational Pathology and Integrative Genomics research team at The Institute of Cancer Research in London, one of the world’s most influential cancer research organizations. There she built a pioneering interface between digital pathology, machine learning, and cancer biology with strong clinical applications.


      Education & Training

      Degree-Granting Education

      2009University of Warwick, GB, Computer Science, Ph.D
      2004University of Warwick, GB, Computer Science, M.Sc
      2003University of Science & Technology of China, CN, Computer Science, B.Sc

      Postgraduate Training

      2010-2012Junior Research Fellow, University of Cambridge
      2009-2012Postdoctoral Fellow, University of Cambridge

      Experience & Service

      Faculty Academic Appointments

      Professor, Computational Pathology, The Institute of Cancer Research, London, 2021 - 2022

      Associate Professor, The Institute of Cancer Research, London, 2017 - 2021

      Assistant Professor, The Institute of Cancer Research, London, 2012 - 2017

      Administrative Appointments/Responsibilities

      Co-Lead, Focus Area One – Quantitative Pathology and Medical Imaging, the Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Director of Computational Pathology Research Program, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Honors & Awards

      2016Cancer Research UK Career Establishment Award
      2012Cancer Research UK Visiting Scholarship Award
      2010University of Cambridge Wolfson College Fellowship

      Selected Publications

      Peer-Reviewed Articles

      1. Hagos, YB, Lecat, CS, Patel, D, Mikolajczak, A, Castillo, SP, Lyon, EJ, Foster, K, Tran, TA, Lee, L, Rodriguez-Justo, M, Yong, K, Yuan, Y. Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies. Cancer Research 84(3):493-508, 2024. e-Pub 2024. PMID: 37963212.
      2. Pan, X, AbdulJabbar, K, Coelho-Lima, J, Grapa, AI, Zhang, H, Cheung, AH, Baena, J, Karasaki, T, Wilson, CR, Sereno, M, Veeriah, S, Aitken, S, Hackshaw, A, Nicholson, A, Jamal-Hanjani, M, Le Quesne, J, Janes, SM, Hacker, AM, Sharp, A, Smith, S, Dhanda, H, Chan, K, Pilotti, C, Leslie, R, Chuter, D, MacKenzie, M, Chee, SJ, Alzetani, A, Lim, E, De Sousa, P, Jordan, S, Rice, A, Raubenheimer, H, Bhayani, H, Ambrose, L, Devaraj, A, Chavan, H, Begum, S, Buderi, SI, Kaniu, D, Malima, M, Booth, S, Fernandes, N, Shah, P, Proli, C, Hewish, M, Danson, S, Shackcloth, M, Robinson, L, Russell, P, Blyth, KG, Kidd, AC, Kirk, A, Asif, M, Bilancia, R, Kostoulas, N, Thomas, M, Dick, C, Lester, JF, Bajaj, A, Nakas, A, Sodha-Ramdeen, A, Tufail, M, Scotland, M, Boyles, R, Rathinam, S, Fennell, D, Wilson, C, Marrone, D, Dulloo, S, Matharu, G, Shaw, J, Riley, J, Primrose, L, Boleti, E, Cheyne, H, Khalil, M, Richardson, S, Cruickshank, T, Price, G, Kerr, K, Benafif, S, Papadatos-Pastos, D, Wilson, JF, Ahmad, T, French, J, Gilbert, K, Naidu, B, Patel, AJ, Osman, A, Lacson, C, Langman, G, Shackleford, H, Djearaman, M, Kadiri, S, Middleton, G, Leek, A, Hodgkinson, JD, Totten, N, Montero, A, Smith, E, Fontaine, E, Granato, F, Novasio, J, Rammohan, K, Joseph, L, Bishop, P, Shah, R, Moss, S, Joshi, V, Crosbie, P, Paiva-Correia, A, Chaturvedi, A, Priest, L, Oliveira, P, Gomes, F, Brown, K, Carter, M, Lindsay, CR, Blackhall, FH, Krebs, M, Summers, Y, Clipson, A, Tugwood, J, Kerr, A, Rothwell, DG, Dive, C, Aerts, HJ, Schwarz, R, Kaufmann, TL, Van Loo, P, Wilson, GA, Rosenthal, R, Rowan, AJ, Bailey, C, Lee, C, Colliver, E, Enfield, K, Hill, MS, Angelova, M, Pich, O, Leung, M, Frankell, AM, Hiley, CT, Lim, E, Zhai, H, Bakir, MA, Birkbak, NJ, Lucas, O, Huebner, A, Puttick, C, Grigoriadis, K, Dietzen, M, Biswas, D, Athanasopoulou, F, Ward, S, Demeulemeester, J, Castignani, C, Cadieux, EL, Kisistok, J, Sokac, M, Szallasi, Z, Diossy, M, Salgado, R, Stewart, A, Magness, A, Weeden, CE, Levi, D, Gronroos, E, Noorani, I, Goldman, J, Escudero, M, Hobson, P, Vendramin, R, Boeing, S, Denner, T, Barbe, V, Lu, WT, Hill, W, Naito, Y, Ramsden, Z, Kassiotis, G, Dwornik, A, Karamani, A, Chain, B, Pearce, DR, Karagianni, D, Galvez-Cancino, F, Stavrou, G, Mastrokalos, G, Lowe, HL, Matos, I, Reading, JL, Hartley, JA, Selvaraju, K, Chen, K, Ensell, L, Shah, M, Litovchenko, M, Chervova, O, Pawlik, P, Hynds, RE, Gamble, S, Ung, SK, Bola, SK, Spanswick, V, Wu, Y, Al-Sawaf, O, Jones, TP, Beck, S, Tanić, M, Marafioti, T, Borg, E, Falzon, M, Khiroya, R, Toncheva, A, Abbosh, C, Richard, C, Naceur-Lombardelli, C, Gimeno-Valiente, F, Thakkar, K, Sunderland, MW, Sivakumar, M, Kanu, N, Prymas, P, Saghafinia, S, Vanloo, S, Lam, JM, Liu, WK, Bunkum, A, Hessey, S, Zaccaria, S, Martínez-Ruiz, C, Black, JR, Thol, K, Bentham, R, Litchfield, K, Mcgranahan, N, Quezada, SA, Forster, M, Lee, SM, Herrero, J, Nye, E, Stone, RK, Nicod, J, Rane, J, Peggs, KS, Ng, KW, Dijkstra, K, Huska, M, Hoogenboom, EM, Monk, F, Holding, JW, Choudhary, J, Bhakhri, K, Scarci, M, Gorman, P, Stephens, RC, Wong, YS, Kaplar, Z, Bandula, S, Watkins, TB, Veiga, C, Royle, G, Collins-Fekete, CA, Fraioli, F, Ashford, P, Procter, AJ, Ahmed, A, Taylor, MN, Nair, A, Lawrence, D, Patrini, D, Navani, N, Thakrar, R, Swanton, C, Yuan, Y, Le Quesne, J, Moore, DA. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nature Cancer 5(2):347-363, 2024. e-Pub 2024. PMID: 38200244.
      3. AbdulJabbar, K, Castillo, SP, Hughes, K, Davidson, H, Boddy, AM, Abegglen, LM, Minoli, L, Iussich, S, Murchison, EP, Graham, TA, Spiro, S, Maley, CC, Aresu, L, Palmieri, C, Yuan, Y. Bridging clinic and wildlife care with AI-powered pan-species computational pathology. Nature communications 14(1), 2023. e-Pub 2023. PMID: 37100774.
      4. Zhang, H, AbdulJabbar, K, Grunewald, T, Akarca, A, Hagos, YB, Sobhani, F, Lecat, CS, Patel, D, Lee, L, Rodriguez-Justo, M, Yong, K, Ledermann, J, Le Quesne, J, Hwang, ES, Marafioti, T, Yuan, Y. Self-supervised deep learning for highly efficient spatial immunophenotyping. EBioMedicine 95, 2023. e-Pub 2023. PMID: 37672979.
      5. Zhang, H, AbdulJabbar, K, Moore, DA, Akarca, A, Enfield, K, Jamal-Hanjani, M, Raza, SE, Veeriah, S, Salgado, R, Mcgranahan, N, Le Quesne, J, Swanton, C, Marafioti, T, Yuan, Y. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma. Cancer Research 83(9):1410-1425, 2023. e-Pub 2023. PMID: 36853169.
      6. Sobhani F, Muralidhar S, Hamidinekoo A, Hall AH, King LM, Marks JR, Maley C, Horlings HM, Hwang ES, Yuan Y. Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ. NPJ Breast Cancer 8(1):105, 2022. e-Pub 2022. PMID: 36109587.
      7. Narayanan PL, Raza SEA, Hall AH, Marks JR, King L, West RB, Hernandez L, Guppy N, Dowsett M, Gusterson B, Maley C, Hwang ES, Yuan Y. Unmasking the immune microecology of ductal carcinoma in situ with deep learning. NPJ Breast Cancer 7(1):19, 2021. e-Pub 2021. PMID: 33649333.
      8. AbdulJabbar K, Raza SEA, Rosenthal R, Jamal-Hanjani M, Veeriah S, Akarca A, Lund T, Moore DA, Salgado R, Al Bakir M, Zapata L, Hiley CT, Officer L, Sereno M, Smith CR, Loi S, Hackshaw A, Marafioti T, Quezada SA, McGranahan N, Le Quesne J, Consortium T, Swanton C, Yuan Y. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nat Med 26(7):1054-1062, 2020. e-Pub 2020. PMID: 32461698.
      9. Failmezger H, Muralidhar S, Rullan A, de Andrea CE, Sahai E, Yuan Y. Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology. Cancer Res 80(5):1199-1209, 2020. e-Pub 2020. PMID: 31874858.
      10. Zormpas-Petridis K, Noguera R, Ivankovic DK, Roxanis I, Jamin Y, Yuan Y. SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology Images. Front Oncol 10:586292, 2020. e-Pub 2020. PMID: 33552964.
      11. Nawaz S, Trahearn NA, Heindl A, Banerjee S, Maley CC, Sottoriva A, Yuan Y. Analysis of tumour ecological balance reveals resource-dependent adaptive strategies of ovarian cancer. EBioMedicine 48:224-235, 2019. e-Pub 2019. PMID: 31648981.
      12. Zormpas-Petridis K, Failmezger H, Raza SEA, Roxanis I, Jamin Y, Yuan Y. Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology. Front Oncol 9:1045, 2019. e-Pub 2019. PMID: 31681583.
      13. Heindl A, Khan AM, Rodrigues DN, Eason K, Sadanandam A, Orbegoso C, Punta M, Sottoriva A, Lise S, Banerjee S, Yuan Y. Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity. Nat Commun 9(1):3917, 2018. e-Pub 2018. PMID: 30254278.
      14. Heindl A, Sestak I, Naidoo K, Cuzick J, Dowsett M, Yuan Y. Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer. J Natl Cancer Inst 110(2), 2018. e-Pub 2018. PMID: 28859291.
      15. Khan AM, Yuan Y. Biopsy variability of lymphocytic infiltration in breast cancer subtypes and the ImmunoSkew score. Sci Rep 6:36231, 2016. e-Pub 2016. PMID: 27812028.
      16. Heindl A, Lan C, Rodrigues DN, Koelble K, Yuan Y. Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer. Oncotarget 7(44):71123-71135, 2016. e-Pub 2016. PMID: 27661102.
      17. Natrajan R, Sailem H, Mardakheh FK, Arias Garcia M, Tape CJ, Dowsett M, Bakal C, Yuan Y. Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis. PLoS Med 13(2):e1001961, 2016. e-Pub 2016. PMID: 26881778.
      18. Savage RS, Yuan Y. Predicting chemoinsensitivity in breast cancer with 'omics/digital pathology data fusion. R Soc Open Sci 3(2):140501, 2016. e-Pub 2016. PMID: 26998311.
      19. Nawaz S, Heindl A, Koelble K, Yuan Y. Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer. Mod Pathol 28(12):1621, 2015. e-Pub 2015. PMID: 26621491.
      20. Lan C, Heindl A, Huang X, Xi S, Banerjee S, Liu J, Yuan Y. Quantitative histology analysis of the ovarian tumour microenvironment. Sci Rep 5:16317, 2015. e-Pub 2015. PMID: 26573438.
      21. Maley CC, Koelble K, Natrajan R, Aktipis A, Yuan Y. An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer. Breast Cancer Res 17(1):131, 2015. e-Pub 2015. PMID: 26395345.
      22. Nawaz S, Heindl A, Koelble K, Yuan Y. Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer. Mod Pathol 28(6):766-77, 2015. e-Pub 2015. PMID: 25720324.
      23. Yuan Y. Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer. J R Soc Interface 12(103), 2015. e-Pub 2015. PMID: 25505134.

      Review Articles

      1. Castillo, SP, Galvez-Cancino, F, Liu, J, Pollard, SM, Quezada, SA, Yuan, Y. The tumour ecology of quiescence. Seminars in cancer biology 92:139-149, 2023. e-Pub 2023. PMID: 37037400.
      2. Sobhani F, Robinson R, Hamidinekoo A, Roxanis I, Somaiah N, Yuan Y. Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology. Biochim Biophys Acta Rev Cancer 1875(2):188520, 2021. e-Pub 2021. PMID: 33561505.
      3. Nawaz S, Yuan Y. Computational pathology: Exploring the spatial dimension of tumor ecology. Cancer Lett 380(1):296-303, 2016. e-Pub 2016. PMID: 26592351.
      4. Yuan Y. Spatial Heterogeneity in the Tumor Microenvironment. Cold Spring Harb Perspect Med 6(8), 2016. e-Pub 2016. PMID: 27481837.
      5. Heindl A, Nawaz S, Yuan Y. Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology. Lab Invest 95(4):377-84, 2015. e-Pub 2015. PMID: 25599534.

      Patents

      1. Scoring of tumour infiltration by lymphocytes. Patent Number: Yinyin Yuan/WO/2016/083791.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Yuan Laboratory

      • Translational Molecular Pathology department

      • Pathology & Laboratory Medicine division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top